OPHIDION, INC.

Basic Information

2265 E. Foothill Blvd
Pasadena, CA, 91107-0000

Company Profile

n/a

Additional Details

Field Value
DUNS: 825379659
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of a5 nicotinic receptor agonists for smoking cessation

    Amount: $386,184.00

    DESCRIPTION provided by applicant Nicotine is a serious health problem that is resistant to treatment for millions of people In the United States tobacco use is responsible for about deat ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  2. Biologic approach to targeting a nicotinic receptor accessory molecule for cognit

    Amount: $656,365.00

    DESCRIPTION (provided by applicant): The proposed project details a biologic strategy for the therapeutic targeting of nicotinic receptors of the cholinergic system for the treatment of mental and ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. In vivo and in vitro tools to target CHRNA5 for smoking cessation.

    Amount: $296,028.00

    DESCRIPTION (provided by applicant): Nicotine is one of the most heavily used addictive drugs and accounts for 90% of lung cancer cases in the U.S. Recent studies have implicated a specialized recepto ...

    STTR Phase I 2011 Department of Health and Human Services
  4. Improved Cell Line and Assay Development of Nicotinic Receptor Complexes for HTS

    Amount: $500,000.00

    DESCRIPTION (provided by applicant): Nicotine consumption is linked to improvements in cognitive functions such as attention and memory, as well as improvements in symptoms for those suffering from di ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government